PeptideDB

IK-930 2563892-44-2

IK-930 2563892-44-2

CAS No.: 2563892-44-2

IK-930 (compound I-32) is a potent orally bioactive TEAD inhibitor (antagonist) with EC50
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

IK-930 (compound I-32) is a potent orally bioactive TEAD inhibitor (antagonist) with EC50 <0.1 µM.

Physicochemical Properties


Molecular Formula C19H19F3N4O2S
Molecular Weight 424.439973115921
Exact Mass 424.118
CAS # 2563892-44-2
PubChem CID 155342988
Appearance White to off-white solid powder
LogP 3
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 6
Heavy Atom Count 29
Complexity 632
Defined Atom Stereocenter Count 0
InChi Key TVBGCXJDLVRDSU-UHFFFAOYSA-N
InChi Code

InChI=1S/C19H19F3N4O2S/c1-23-29(27,28)15-7-8-17(16(9-15)18-11-26(2)12-25-18)24-10-13-3-5-14(6-4-13)19(20,21)22/h3-9,11-12,23-24H,10H2,1-2H3
Chemical Name

N-methyl-3-(1-methylimidazol-4-yl)-4-[[4-(trifluoromethyl)phenyl]methylamino]benzenesulfonamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets TEAD[1]
ln Vivo IK-930 (compound I-32) (10 mg/kg; po) in BALB/c mice shows favorable pharmacokinetic characteristics, with an AUC 0-last of 4581 ng*h /mL and a Cmax of 1088 ng/mL[1].
References

[1]. Tead inhibitors and uses thereof. WO2020243415A2.

Additional Infomation IK-930 is an oral, paralog-selective TEAD inhibitor.

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (235.60 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.89 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.89 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.3560 mL 11.7802 mL 23.5605 mL
5 mM 0.4712 mL 2.3560 mL 4.7121 mL
10 mM 0.2356 mL 1.1780 mL 2.3560 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.